authors
- Swierkosz, TA
- Kapoor, S
- Tardiff, DC
- Hirshfeld, JW
- Klugherz, BD
- Kolansky, DM
- Magness, K
- Valettas, Nicholas
- Wilensky, RL
- Herrmann, HC
Does greater platelet inhibition explain abciximab's superiority in the TARGET trial? A randomized clinical comparison.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 23, 2001
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal